Swiss Re

In October 2003 it announced that it would become a carbon neutral business within ten years.[1]. In the area of analytical chemistry, Merck played a leading role in the development of chromatographic methods. Its new London headquarters are located in the award-winning 30 St Mary Axe tower, completed in 2004. In the chemical-research sector, work started on pearl-lustre pigments in 1957, while the company's involvement in liquid crystals was initiated ten years later leading to its market leading role today. It was founded in 1863 by the forerunner of Credit Suisse. Successful pharmaceutical agents of this time included corticoid preparations — for example Fortecortin, which is still used today —, the cold remedy Nasivin or the hormone preparations Gestafortin and Menova. It employs around 8500 people. For Merck this meant two-digit sales-growth figures for many years.

The company's headquarters are in Zürich, Switzerland. Soon afterwards the boom commonly known as the "Wirtschaftswunder" (economic miracle) set in. Swiss Re is the world's second-largest reinsurance company (after Munich Re/ Münchener Rück), and the world's largest life and health reinsurer. Following the defeat of Germany in World War II, Merck was granted permission by the military government to produce drugs, pesticides, food preservatives, reagents, and fine chemicals for laboratory use. Attention was directed at vitamins as a new product category, and Vigantol was introduced in 1927, followed by Cebion in 1934. Around World War I, Merck began producing and later patented MDMA (ecstasy).

Sigmund Freud, author of Über Coca (1884), was an enthusiastic collaborator in Merck's coca research, though the methodological sophistication of his self-experimentation studies has been challenged. From 1884 onwards, Merck played a vigorous role too in the production and marketing of cocaine. After Wilhelm Adam Sertürner's isolation of morphine from opium in 1805, Merck pioneered (from 1827) the commercial manufacture of morphine for an expanding global market. Many popular and successful products have emerged from Merck's laboratories.

It is one of the top 5 pharmaceutical companies worldwide, much larger than its German ancestor, which employees around 28,600 people in 54 countries. Today, the US company has about 70,000 employees in 120 countries and 31 factories worldwide. was confiscated following the First World War and set up as an independent company in the United States. Merck & Co.

in New York, USA. In 1891, George Merck established his roots in the United States and set up Merck & Co. He and his successors gradually built up a chemical-pharmaceutical factory that produced — in addition to raw materials for pharmaceutical preparations — a multitude of other chemicals and (from 1890) medicines. He began manufacturing of these substances "in bulk" in 1827, toting them as a "Cabinet of Pharmaceutical and Chemical Innovations" for sale.

Thanks to his good scientific education he was successful in isolating and characterizing alkaloids in the pharmacy laboratory. In 1816, Emanuel Merck took over the pharmacy. In 1668, Friedrich Jacob Merck, an apothecary, assumed ownership of the "Engel-Apotheke" (Angel Pharmacy) in Darmstadt, Germany. The roots of Merck reach back into the 17th Century.

Merck has a colorful and varied history. It operates under the umbrella brand EMD in North America, formed from the initials of Emanuel Merck, Darmstadt. The German based pharmaceutical company operates mainly in Europe. Merck KGaA (also referred to as “German Merck” or “Merck Darmstadt”) is one of the oldest still operating chemical-pharmaceutical companies in the world established in 1668.

Merck & Co., called Merck Sharp and Dohme (MSD) outside the USA and Canada, is now an independent company. subsidiary in the United States. Following World War I, Merck lost possession of its foreign sites including the Merck & Co. Merck was founded in Germany and until going partly public in 1995 privately owned.

Merck KGaA is a German based pharmaceutical company.